CD34 Cell ImmunoGraft® Platform

Humanized mouse models with a functional human immune system can be achieved by transplanting CD34+ hematopoetic stem cells  from umbilical cord blood, into immunodeificent mice.  Champions Oncology offers these studies as an ImmunoGraft® platform in which humanized immune system mice are co-engrafted with a PDX or CDX model and evaluated efficacy with therapeutic drugs and standards of care to evaluate immune-oncology agents.

Champions Oncology’s CD34+ ImmunoGraft Platform

Champions Oncology’s CD34+ ImmunoGraft® Platform